Efficacy Of Tiragolumab Plus Atezolizumab In Pd-L1 Ihc And Tigit Subgroups In The Phase Ii Cityscape Study In First-Line Nsclc
JOURNAL OF THORACIC ONCOLOGY(2021)
关键词
Tiragolumab, PD-L1-positive metastatic NSCLC, TIGIT
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要